Healx Overview
Founded
2014
Status
Private
Employees
50
Latest Deal Type
Series B
Latest Deal Amount
$56M
Investors
16
Healx General Information
Description
Developer of a drug discovery platform intended to accelerate the discovery of new treatments for rare diseases. The company's platform uses artificial intelligence to leverage the combination of algorithms to predict and de-risk novel connections in biomedical data and move the promising ones towards the clinic, enabling clinics to develop advanced treatment methods.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Primary Office
- Charter House
- 66-68 Hills Road
- Cambridge CB2 1LA
- England, United Kingdom
Healx Timeline
Healx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series B) | 16-Oct-2019 | $56M | 000.00 | Completed | Generating Revenue | |
| 5. Early Stage VC (Series A) | 26-Jul-2018 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A) | 05-Oct-2016 | 00.000 | 00.00 | 000.00 | Completed | Startup |
| 3. Seed Round | 15-Apr-2015 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Grant | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Startup |
Healx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A Pref | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 2,878,000 | $0.000000 | $0.69 | $0.69 | 1x | $0.69 | 13.49% | |
| Ordinary | 2,484,000 | $0.000000 | $0.16 | $0.16 | 1x | $0.16 | 11.64% |
Healx Competitors (20)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verge Genomics | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000000 | Venture Capital-Backed | Oxford, United Kingdom | 00 | 00000 | 00000000000 | 00000 |
| 00000000 00000000 | Venture Capital-Backed | Hong Kong, Hong Kong | 00 | 000.00 | 00000 00000 | 000.00 |
| 00000 | Venture Capital-Backed | New York, NY | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 | Corporation | Charlottesville, VA | 000 | 0000000000 | 000 |
Healx Executive Team (21)
6 Former Executives
Healx Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Brown Ph.D | Healx | Co-Founder & Chairman | 000 0000 |
| Irina Haivas MD | Atomico | Board Member | 000 0000 |
| Jonathan Milner Ph.D | Self | Board Member | 000 0000 |
| Shaun Grady | Self | Board Member | 000 0000 |
| Suranga Chandratillake | Balderton Capital | Board Member | 000 0000 |
1 Former Board Member
Healx Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Atomico | Venture Capital | Minority | 000 0000 | 000000 0 | |
| b-to-v Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Global Brain | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Intel Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| R42 Group | Venture Capital | Minority | 000 0000 | 000000 0 |
Healx Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 19-Aug-2017 | 000000000000000000 | Business/Productivity Software |
Ready to get started?
Request a free trial